FMRP (Darnell et al, 2011 ) is elevated at the synapses of Fmr1 KO mice (Gross et al, 2010; Sharma et al, 2010) , providing a functional link between loss of FMRP and overactivated mTOR signaling (Figure 1 ). These findings identify dysregulation of mTOR signaling as a phenotypic feature common to FXS, TSC1 and 2, NF1, and PTEN-associated autism syndromes. Whereas other syndromic ASDs arise from mutations in components of the PI3K-mTOR pathway, FXS arises from silencing of the gene encoding FMRP, an RNA-binding protein that represses translation of a large array of RNAs including PIKE. This, in turn, results in elevation of PIKE and overactivation of PI3K-mTOR signaling. These observations raise the possibility that dysregulation of mTOR may be a unifying theme in a growing number of ASDs and ASD-associated syndromes.
On the basis of the clear link between overactivated mTOR signaling and autism, the mTOR pathway represents a promising therapeutic target for the treatment of ASDs. Treatment with the mTORC1 inhibitor rapamycin has shown promising results in PTEN knockout mice (Zhou et al, 2009 ) and TSC2 + /À mice (Ehninger et al, 2008) . Thus, interventions that target mTOR signaling should be at the leading edge of future translational research in the autism field. 
DISCLOSURE

Habenular Signaling in Nicotine Reinforcement
Tobacco dependence is a complex genetic trait, with greater than 50% of the risk of developing dependence attributable to genetic factors (Li et al, 2003) . Nicotine, the major psychoactive component in tobacco smoke responsible for dependence, functions in the brain through neuronal nicotinic acetylcholine receptors (nAChRs). A major breakthrough in understanding the genetics of tobacco dependence was the finding that allelic variation in the CHRNA3-CHRNA5-CHRNB4 gene cluster, which encodes the a3, a5, and b4 nAChR subunits, respectively, increases vulnerability to Our findings support a model where, in WT mice, FMRP represses PIKE, an upstream activator of PI3K signaling and identified target of FMRP, and thereby inhibits mTOR signaling. Upon activation, group I mGluRs act via Gq and Homer to bind PIKE and engage PI3K signaling, which activates mTOR. mTOR drives cap-dependent translation and local synthesis of synaptic proteins such as Arc, Map1b, CaMII, and PSD-95, critical to mGluR-LTD. In addition, mTOR regulates LIMK and cofilin, which promote spine morphogenesis. In mice lacking FMRP, PIKE is derepressed, resulting in overactivation of mTOR, accumulation of synaptic proteins, and exaggerated, protein synthesisindependent LTD. The PI3K inhibitor LY294002 corrects p-mTOR and restores DHPG sensitivity. A prediction of the model is that dysregulation of mTOR signaling contributes to the cognitive and social interaction deficits observed in humans with Fragile X.
tobacco dependence and smokingassociated diseases (Bierut et al, 2008; Thorgeirsson et al, 2008) . In particular, a polymorphism in CHRNA5 (rs16969968) that results in an aspartic acid to asparagine substitution at amino-acid reside 398 (D398N) more than doubles the risk of tobacco dependence in those carrying two copies of the risk allele. Little was known about how nAChRs-containing a5, a3, and/or b4 subunits may contribute to tobacco dependence. However, recent findings suggest that nAChRs containing these subunits play a key role in regulating nicotine reinforcement.
The a3, a5, and b4 nAChR subunits are densely expressed in the medial habenula (MHb) and its major site of projection, the interpeduncular nucleus (IPN) (Salas et al, 2009). Our laboratory has recently shown that mice with null mutation in the a5 nAChR subunit gene intravenously self-administer significantly greater quantities of nicotine than their wildtype counterparts, particularly when higher unit doses of the drug are available for consumption (Fowler et al, 2011) . This enhanced intake in the mutant mice was ameliorated by virus-mediated re-expression of a5 nAChR subunits in the MHb-IPN tract. In addition, we found that IPN neurons were insensitive to nicotine in the mutant mice, reflected in greatly diminished induction of Fos immunoreactivity in response to nicotine injections. Moreover, lidocaine-induced inactivation of the MHb or IPN increased nicotine self-administration in rats, particularly at higher units doses of the drug. Finally, virusmediated knockdown of a5 nAChR subunits in the MHb-IPN tract did not alter the reward-enhancing properties of lower nicotine doses, but greatly attenuated the reward-inhibiting (ie, aversive) effects of higher nicotine doses in rats (Fowler et al, 2011) . In keeping with these findings, overexpression of b4 nAChR subunits in the MHb-IPN tract enhanced aversion to nicotine and reduced consumption of the drug in mice (Frahm et al, 2011) . Moreover, virus-mediated expression in the MHb of a major risk allele of the a5 subunit gene (D398N allele), which decreases the function of a5-containing nAChRs incorporating this risk allele and increases vulnerability to tobacco dependence in humans, reduced aversion to nicotine and enhanced nicotine intake in the b4 subunit-overexpressing mice (Frahm et al, 2011) . Hence, nAChRscontaining a5 and/or b4 subunits regulate the activation of the MHb-IPN tract in response to nicotine, which signals aversion to the drug. Deficient nAChR signaling in the MHb-IPN tract, which likely occurs in humans carrying risk alleles in the CHRNA3-CHRNA5-CHRNB4 gene cluster, reduces nicotine aversion and results in greater consumption of the drug. As such, these finding reveal fundamental new insights into the mechanisms of nicotine reinforcement and the neurocircuitry of tobacco dependence. Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. 
